Skip to main content
HR 1829 117th Congress House Health Congressional oversight Drug therapy Government employee pay, benefits, personnel management Government studies and investigations Health care costs and insurance Inflation and prices Medicaid Medicare Prescription drugs

Pharmacy Benefit Manager Accountability Study Act of 2021

Introduced: August 12, 2022 Introduced by: Harshbarger, Diana Republican · Tennessee See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 12, 2021
Referred to the Subcommittee on Health.
Mar 11, 2021
Referred to the House Committee on Energy and Commerce.
Mar 11, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Pharmacy Benefit Manager Accountability Study Act of 2021

This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit managers.

What's happening now March 12, 2021

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • S 298 Identical bill Pharmacy Benefit Manager Accountability Study Act of 2021
  • S 4293 Related bill Pharmacy Benefit Manager Transparency Act of 2022
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 29
All 29 Democratic 2 Republican 18
R
Mace, Nancy
South Carolina · Dec 7, 2022
 R
Cammack, Kat
Florida · Sep 19, 2022
 R
Cline, Ben
Virginia · Sep 19, 2022
Herrell, Yvette
· Aug 12, 2022
 R
Kelly, Mike
Pennsylvania · Jul 26, 2022
 R
Mann, Tracey
Kansas · Jul 11, 2022
 R
Owens, Burgess
Utah · Jun 13, 2022
Phillips, Dean
· May 16, 2022
Davis, Rodney
· Apr 25, 2022
 R
Miller, Mary E.
Illinois · Apr 21, 2022
 R
Norman, Ralph
South Carolina · Apr 21, 2022
 R
Perry, Scott
Pennsylvania · Mar 29, 2022
 R
Thompson, Glenn
Pennsylvania · Feb 1, 2022
 R
Grothman, Glenn
Wisconsin · Jan 19, 2022
 D
Cohen, Steve
Tennessee · Nov 1, 2021
CHABOT, STEVE
· Oct 25, 2021
Rosendale, Matthew
· Oct 25, 2021
 R
Guest, Michael
Mississippi · Jun 28, 2021
 R
Miller-Meeks, Mariannette
Iowa · Jun 28, 2021
 R
Murphy, Gregory F.
North Carolina · Jun 28, 2021
 R
Spartz, Victoria
Indiana · Jun 28, 2021
 D
Welch, Peter
Vermont · Jun 22, 2021
Axne, Cynthia
· Jun 17, 2021
Posey, Bill
· Mar 26, 2021
 R
Griffith, H. Morgan
Virginia · Mar 19, 2021
Keller, Fred
· Mar 18, 2021
Carl, Jerry
· Mar 16, 2021
 R
Van Drew, Jefferson
New Jersey · Mar 16, 2021
 R
Carter, Earl L. "Buddy"
Georgia · Mar 11, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1829: Pharmacy Benefit Manager Accountability Study Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1829/
MLA
"H.R. 1829: Pharmacy Benefit Manager Accountability Study Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1829/.
Bluebook (legal)
H.R. 1829, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1829/.
Markdown link
[H.R. 1829: Pharmacy Benefit Manager Accountability Study Act of 2021](https://openamerica.io/bill/117-HR-1829/)
Report a problem